Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity
Vaccines · 31.07.2023 · 11 (8) · 1309
DOI: 10.3390/vaccines11081309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 31.07.2023. Verfasst von João Guilherme Lino da Silva und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministério da Saúde, Departamento de Ciência e Tecnologia (DECIT), Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).
Abstract (Originalsprache)
Recent studies suggest that the association of antigens in microparticles increases the anti-Leishmania vaccine immunogenicity. This study aims to investigate the in situ effect of the adjuvant performance consisting of chitosan-coated poly(D,L-lactic) acid submicrometric particles (SMP) and analyze the inflammatory profile and toxicity. Two formulations were selected, SMP1, containing poly(D,L-lactide) (PLA) 1% wt/v and chitosan 1% wt/v; and SMP2, containing PLA 5% wt/v and chitosan 5% wt/v. After a single dose of the unloaded SMP1 or SMP2 in mice, the SMPs promoted cell recruitment without tissue damage. In addition, besides the myeloperoxidase (MPO) activity having demonstrated similar results among the analyzed groups, a progressive reduction in the levels of N-acetyl-β-D-glucosaminidase (NAG) until 72 h was observed for SMPs. While IL-6 levels were similar among all the analyzed groups along the kinetics, only the SMPs groups had detectable levels of TNF-α. Additionally, the Leishmania braziliensis antigen was encapsulated in SMPs (SMP1Ag and SMP2Ag), and mice were vaccinated with three doses. The immunogenicity analysis by flow cytometry demonstrated a reduction in NK (CD3−CD49+) cells in all the SMPs groups, in addition to impairment in the T cells subsets (CD3+CD4+) and CD3+CD8+) and B cells (CD19+) of the SMP2 group. The resulting data demonstrate that the chitosan-coated SMP formulations stimulate the early events of an innate immune response, suggesting their ability to increase the immunogenicity of co-administered Leishmania antigens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil.
- Nucleus for Research in Biological Sciences (NUPEB), Federal University of Ouro Preto, Ouro Preto 35400-000, Brazil.
- Laboratory of Pharmaceutics and Nanotechnology (LDGNano), School of Pharmacy, Federal University of Ouro Preto, Ouro Preto 35400-000, Brazil.
- Integrated Research Group on Biomarkers, René Rachou Research Center, Oswaldo Cruz Foundation, Belo Horizonte 30190-009, Brazil.
- National Institute of Science and Technology in Tropical Diseases, INCT-DT, Salvador 40110-060, Brazil.
- Laboratory of Diagnosis and Monitoring Biomarkers, René Rachou Research Center, Oswaldo Cruz Foundation, Belo Horizonte 30190-009, Brazil.
ORCID-Profile: João Guilherme Lino da Silva, Ana Alice Maia Gonçalves, Alexsandro Sobreira Galdino, Vanessa Carla Furtado Mosqueira, Rodolfo Cordeiro Giunchetti
Förderung
- Ministério da Saúde, Departamento de Ciência e Tecnologia (DECIT)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais (INCT-DT)
Zitieren
APA
Silva, J. G. L. D., Gonçalves, A. A. M., Oliveira, L. T., Garcia, G. M., Batista, M. A., Mendonça, L. Z., Viana, K. F., Sant'Ana, R. C. O., Melo Júnior, O. A. O., Silveira-Lemos, D., Dutra, W. O., Martins-Filho, O. A., Galdino, A. S., de Moura, S. A. L., Mosqueira, V. C. F., & Giunchetti, R. C. (2023). Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity. Vaccines, 11(8), 1309. https://doi.org/10.3390/vaccines11081309
Vancouver
Silva JGLD, Gonçalves AAM, Oliveira LT, Garcia GM, Batista MA, Mendonça LZ, et al. Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity. Vaccines. 2023;11(8):1309. doi:10.3390/vaccines11081309
BibTeX
@article{Silva2023,
author = {Silva, João Guilherme Lino da and Gonçalves, Ana Alice Maia and Oliveira, Liliam Teixeira and Garcia, Giani Martins and Batista, Maurício Azevedo and Mendonça, Ludmila Zanandreis de and Viana, Kelvinson Fernandes and Sant'Ana, Rita de Cássia Oliveira and Melo Júnior, Otoni Alves de Oliveira and Silveira-Lemos, Denise and Dutra, Walderez Ornelas and Martins-Filho, Olindo Assis and Galdino, Alexsandro Sobreira and de Moura, Sandra Aparecida Lima and Mosqueira, Vanessa Carla Furtado and Giunchetti, Rodolfo Cordeiro},
title = {Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {8},
pages = {1309},
doi = {10.3390/vaccines11081309}
}
EUVIMED